There are 3163 resources available
67O - Polygenic risk score associations with immune checkpoint inhibitors related endocrine toxicity
Presenter: Christian Thorball
Session: Proffered paper session 2: Basic science & Translational research
Resources:
Abstract
Slides
Webcast
1541MO - Leadership roles in oncology: Gender is still a barrier. Results from the new ESMO Women for Oncology Committee authorship and monitoring studies
Presenter: Helena Linardou
Session: Mini oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
1207MO - Neoadjuvant nivolumab monotherapy for high-risk clinical stage I non-small cell lung cancer: A phase II POTENTIAL study
Presenter: Yasuhiro Tsutani
Session: Mini oral session 2: Non-metastatic NSCLC
Resources:
Abstract
Slides
Webcast
Invited Discussant 1718O and 1719O
Presenter: Claudia María Valverde Morales
Session: Proffered paper session: Sarcoma
Resources:
Slides
Webcast
Do we have clinical or radiological biomarkers to guide us?
Presenter: Roberto Ferrara
Session: Which patients should we treat beyond progression and when should we stop?
Resources:
Slides
Webcast
Sex and gender: First steps towards tailored treatment
Presenter: Kathrin Heinrich
Session: New technology, new ideas: What is on the horizon for colorectal cancer?
Resources:
Slides
Webcast
CNS disease
Presenter: Nancy Lin
Session: Management of oligoprogressive disease
Resources:
Slides
Webcast
The role of immunotherapy plus concurrent chemoradiation
Presenter: Dina Najjari Jamal
Session: How can we best manage locally-advanced and persistent cervical cancers?
Resources:
Slides
Webcast
Invited Discussant 1141O and 1142O
Presenter: Nicola Fazio
Session: Proffered paper session: NETs and endocrine tumours
Resources:
Slides
Webcast
Invited Discussant 66O and 67O
Presenter: Aurélien Marabelle
Session: Proffered paper session 2: Basic science & Translational research
Resources:
Slides
Webcast